As discussed below, these genetically modified mice have been successfully used in disease models including inflammatory bowel disease, acute lung injury, liver cancer and Alzheimer’s disease (AD), providing useful information for the future development of SAA-based therapeutics. The gene discussed is SAA1; the disease is inflammatory bowel disease.